Blog

Royal Bank (RY) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended January 2026. This widely-known consensus outlook gives

Wall Street expects a year-over-year increase in earnings on higher revenues when Vistra Corp. (VST) reports results for the quarter ended December 2025. While this widely-known consensus outlook

Liberty Media Corporation - Liberty Formula One Series C (FWONK) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended

Wall Street expects a year-over-year decline in earnings on lower revenues when Curaleaf Holdings, Inc. (CURLF) reports results for the quarter ended December 2025. While this widely-known consensus

The market expects MP Materials Corp. (MP) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus

The market expects Dentsply International (XRAY) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known

Viatris (VTRS) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook gives a

Wall Street expects a year-over-year increase in earnings on lower revenues when Energy Fuels (UUUU) reports results for the quarter ended December 2025. While this widely-known consensus outlook is

The market expects TeraWulf Inc. (WULF) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus

Wall Street expects a year-over-year decline in earnings on higher revenues when Cheniere Energy (LNG) reports results for the quarter ended December 2025. While this widely-known consensus outlook

Wall Street expects a year-over-year increase in earnings on higher revenues when Kimbell Royalty (KRP) reports results for the quarter ended December 2025. While this widely-known consensus

Marcus (MCS) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook gives a

Life360 (LIF) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook gives

The market expects Shake Shack (SHAK) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus

Entrada Therapeutics, Inc. (TRDA) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known

For the quarter ended December 2025, Integer (ITGR) reported revenue of $472.06 million, up 5% over the same period last year. EPS came in at $1.76, compared to $1.43 in the year-ago quarter.

The

LKQ (LKQ) reported $3.31 billion in revenue for the quarter ended December 2025, representing a year-over-year decline of 1.3%. EPS of $0.59 for the same period compares to $0.80 a year ago.

The

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, February 19:

Vertiv Holdings Co VRT: This critical digital infrastructure technologies

Shares of LiveRamp (RAMP) have gained 0.4% over the past four weeks to close the last trading session at $25.11, but there could still be a solid upside left in the stock if short-term price targets

LiveOne (LVO) closed the last trading session at $5.2, gaining 21.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Shares of Zebra Technologies (ZBRA) have gained 3.9% over the past four weeks to close the last trading session at $252.52, but there could still be a solid upside left in the stock if short-term

Shares of Aldeyra Therapeutics, Inc. (ALDX) have gained 0.6% over the past four weeks to close the last trading session at $5.02, but there could still be a solid upside left in the stock if

Regency Centers Corporation (REG) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, REG's 50-day simple moving average

Collegium Pharmaceutical COLL is scheduled to report its fourth-quarter and full-year 2025 results on Feb. 26, before the opening bell. The company’s commercial portfolio currently comprises Jornay

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different